Organ Transplantation Market 2022 | Market Growth, Opportunities, and Forecast to 2030
Organ transplantation is one of the significant
developments in modern-day medicine. Organ transplantation is a medical
procedure in which the organ is removed from one body and transferred to
another body to replace the organ that is missing or damaged. One of the major
aspects of organ transplantation is the approval of the patient or the
patient's family. Organ harvesting without prior permission is illegal and a
serious crime. Organ transplantation is typically performed with a brain-dead
patient whose other organs are healthy and can be used to save another person's
life.
The Organ Transplantation Market, share is expected to grow USD 12.4
billion compound annual growth rate of 9.50% during the period of forecast
2022-2030.
This procedure is performed to treat organ
failure in the lungs, liver, kidneys, and many others. Kidney is the most
broadly transplanted organ followed by the liver. Unfortunately, the demand for
organ donations is even more significant than the number of individuals
donating organs. As per the National Kidney Foundation, more than 3,000 new
patients are added to the kidney waiting list every month. As stated by the
United Network for Organ Sharing, 21 people die every day in the United States
waiting for an organ, and more than 120,000 men, women, and children are
waiting for life-saving organ transplants.
Market Dynamics
The key driver of organ transplant demand is
the rise in the prevalence of chronic diseases and organ failure. Increased
incidence of kidney disease, over-consumption of alcohol, and insalubrious
diets have led to the development of the organ transplantation market. Whereas
the high costs of transplantation, the small number of donors, and the rising
incidence of organ failure have restricted the industry's growth.
Market Segmentation
The global market for organ transplantation has
been segmented into type, product, type of transplant, treatment, and
end-users.
·
Based on type,
the global market for organ transplantation has been segmented into organs,
heart, kidney, liver, lungs, and other.
·
Based on products, the global market for organ transplantation has been segmented into
organ preservation solutions, transplant diagnostics, tissue products, and
others.
·
Based on the type of transplant, the global market for organ transplantation
has been segmented into autograft, xenograft and xenotransplantation, allograft
and allotransplantation, and others.
·
Based on treatment, the global market for organ transplantation has been segmented into
immunosuppressant, analgesic, and other. Immunosuppressant is further divided
into calcineurin inhibitors, mTOR inhibitor, antiproliferative agents,
steroids, and others. Calcineurin Inhibitors are sub-segmented into tacrolimus
and cyclosporine. mTOR inhibitor is sub-segmented into sirolimus and
everolimus.
·
Based on end-users, the global market for organ transplantation has been segmented into
hospitals, transplant centers, and others.
Key Drivers
Some of the leading participants in the global Organ Transplantation Market Players are Terumo Medical Corporation
(US), Transonic (US), F. Hoffmann-La Roche Ltd. (Switzerland), Novartis
International AG (Switzerland), OrganOX Limited (UK), Bio Med Pvt. Ltd. (US),
Astellas Pharma, Inc (Japan), Transplant Biomedical (UK), TransMedic, Inc.
(US), Accord Healthcare GmbH (Spain), Preservation Solutions, Inc. (US), Sanofi
(France), Pfizer, Inc. (US), Veloxis Pharmaceuticals A/S (Denmark),
GlaxoSmithKline Plc. (UK).
Regional Analysis
Region-wise, the global market for organ
transplantation has been segmented into the Americas, Europe, Asia Pacific, and
Middle East & Africa.
The Americas dominates the worldwide demand for
organ transplantation. Increasing prevalence of organ failure, rapid advances
in the medical industry, well-developed healthcare systems, and higher spending
on health care are critical factors in the growth of the American market.
Europe is the second-largest organ
transplantation market, followed by the Asia Pacific.
The Asia Pacific is the fastest-growing region
on the market. The presence of emerging economies and a large population
suffering from chronic diseases is the main driver for the Asia Pacific market.
Industry Trends/Updates
- Dr
Robert Redfield, a transplant surgeon at UW hospital, has teamed up with
another expert for using pigs as organ donors for organ transplantation.
They plan to create pigs who can be customized to needs of kidney,
pancreases, or another organ transplant.
- In
May 2018, China was appreciated at the 71st World Health Assembly (WHA)
for its model and experience in organ transplantation. China's model of
organ donation and transplantation reflects strong government support and
a robust healthcare sector.
- The
National Institutes of Health announced the launch of a new clinical trial
which might pave the way for HIV-to-HIV kidney transplant. The trail is
the zenith of almost a decade of work and will include 160 kidney
transplants to HIV-positive patients.
Related Report-
·
Intussusception Market Research Report- Global Forecast till 2027
·
Corneal Transplant Market Research Report - Global forecast till 2027
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment